Beacon Pointe Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,100	Closed	-$226K	–	1023
2022 Q2	$226K	Buy	+9,100	New	+$226K	﹤0.01%	934
2021 Q1	–	Sell	-3,500	Closed	-$318K	–	544
2020 Q4	$318K	Buy	+3,500	New	+$318K	0.02%	354